nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP3A5—Ifosfamide—testicular cancer	0.106	0.15	CbGbCtD
Ranitidine—CYP2C19—Ifosfamide—testicular cancer	0.0858	0.121	CbGbCtD
Ranitidine—SLC22A8—Methotrexate—testicular cancer	0.0705	0.0991	CbGbCtD
Ranitidine—ABCB1—Dactinomycin—testicular cancer	0.0586	0.0825	CbGbCtD
Ranitidine—CYP3A5—Etoposide—testicular cancer	0.0508	0.0715	CbGbCtD
Ranitidine—CYP3A4—Ifosfamide—testicular cancer	0.0415	0.0584	CbGbCtD
Ranitidine—CYP1A2—Etoposide—testicular cancer	0.0378	0.0532	CbGbCtD
Ranitidine—ABCB1—Vinblastine—testicular cancer	0.0367	0.0517	CbGbCtD
Ranitidine—CYP2D6—Vinblastine—testicular cancer	0.0346	0.0487	CbGbCtD
Ranitidine—ABCB1—Cisplatin—testicular cancer	0.0337	0.0474	CbGbCtD
Ranitidine—ABCB1—Etoposide—testicular cancer	0.0331	0.0466	CbGbCtD
Ranitidine—ABCB1—Doxorubicin—testicular cancer	0.0226	0.0318	CbGbCtD
Ranitidine—CYP3A4—Vinblastine—testicular cancer	0.022	0.031	CbGbCtD
Ranitidine—ABCB1—Methotrexate—testicular cancer	0.0219	0.0308	CbGbCtD
Ranitidine—CYP2D6—Doxorubicin—testicular cancer	0.0213	0.0299	CbGbCtD
Ranitidine—CYP3A4—Etoposide—testicular cancer	0.0198	0.0279	CbGbCtD
Ranitidine—CYP3A4—Doxorubicin—testicular cancer	0.0135	0.019	CbGbCtD
Ranitidine—Dizziness—Vinblastine—testicular cancer	0.000531	0.00183	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000528	0.00182	CcSEcCtD
Ranitidine—Myalgia—Cisplatin—testicular cancer	0.000521	0.0018	CcSEcCtD
Ranitidine—Feeling abnormal—Dactinomycin—testicular cancer	0.000521	0.0018	CcSEcCtD
Ranitidine—Nausea—Chlorambucil—testicular cancer	0.00052	0.0018	CcSEcCtD
Ranitidine—Ill-defined disorder—Etoposide—testicular cancer	0.00052	0.0018	CcSEcCtD
Ranitidine—Anaemia—Etoposide—testicular cancer	0.000518	0.00179	CcSEcCtD
Ranitidine—Dyspnoea—Ifosfamide—testicular cancer	0.000517	0.00179	CcSEcCtD
Ranitidine—Somnolence—Ifosfamide—testicular cancer	0.000515	0.00178	CcSEcCtD
Ranitidine—Discomfort—Cisplatin—testicular cancer	0.000515	0.00178	CcSEcCtD
Ranitidine—Vomiting—Vinblastine—testicular cancer	0.00051	0.00176	CcSEcCtD
Ranitidine—Malaise—Etoposide—testicular cancer	0.000506	0.00175	CcSEcCtD
Ranitidine—Breast disorder—Methotrexate—testicular cancer	0.000504	0.00174	CcSEcCtD
Ranitidine—Vertigo—Etoposide—testicular cancer	0.000504	0.00174	CcSEcCtD
Ranitidine—Headache—Vinblastine—testicular cancer	0.000503	0.00174	CcSEcCtD
Ranitidine—Leukopenia—Etoposide—testicular cancer	0.000502	0.00173	CcSEcCtD
Ranitidine—Abdominal pain—Dactinomycin—testicular cancer	0.0005	0.00173	CcSEcCtD
Ranitidine—Body temperature increased—Dactinomycin—testicular cancer	0.0005	0.00173	CcSEcCtD
Ranitidine—Anaphylactic shock—Cisplatin—testicular cancer	0.000499	0.00173	CcSEcCtD
Ranitidine—Hypersensitivity—Bleomycin—testicular cancer	0.000499	0.00173	CcSEcCtD
Ranitidine—Cardiac arrest—Epirubicin—testicular cancer	0.000496	0.00172	CcSEcCtD
Ranitidine—Pain—Ifosfamide—testicular cancer	0.000495	0.00171	CcSEcCtD
Ranitidine—Constipation—Ifosfamide—testicular cancer	0.000495	0.00171	CcSEcCtD
Ranitidine—Thrombocytopenia—Cisplatin—testicular cancer	0.000489	0.00169	CcSEcCtD
Ranitidine—Blood creatinine increased—Epirubicin—testicular cancer	0.000489	0.00169	CcSEcCtD
Ranitidine—Tachycardia—Cisplatin—testicular cancer	0.000487	0.00169	CcSEcCtD
Ranitidine—Hyperhidrosis—Cisplatin—testicular cancer	0.000483	0.00167	CcSEcCtD
Ranitidine—Pruritus—Bleomycin—testicular cancer	0.00048	0.00166	CcSEcCtD
Ranitidine—Feeling abnormal—Ifosfamide—testicular cancer	0.000477	0.00165	CcSEcCtD
Ranitidine—Chest pain—Etoposide—testicular cancer	0.000477	0.00165	CcSEcCtD
Ranitidine—Eosinophilia—Methotrexate—testicular cancer	0.000477	0.00165	CcSEcCtD
Ranitidine—Nausea—Vinblastine—testicular cancer	0.000477	0.00165	CcSEcCtD
Ranitidine—Abdominal pain upper—Epirubicin—testicular cancer	0.000477	0.00165	CcSEcCtD
Ranitidine—Pancreatitis—Methotrexate—testicular cancer	0.000473	0.00163	CcSEcCtD
Ranitidine—Discomfort—Etoposide—testicular cancer	0.000472	0.00163	CcSEcCtD
Ranitidine—Breast disorder—Epirubicin—testicular cancer	0.000472	0.00163	CcSEcCtD
Ranitidine—Hypotension—Cisplatin—testicular cancer	0.000467	0.00161	CcSEcCtD
Ranitidine—Hypersensitivity—Dactinomycin—testicular cancer	0.000466	0.00161	CcSEcCtD
Ranitidine—Abdominal discomfort—Methotrexate—testicular cancer	0.000462	0.0016	CcSEcCtD
Ranitidine—Confusional state—Etoposide—testicular cancer	0.000461	0.00159	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.00046	0.00159	CcSEcCtD
Ranitidine—Urticaria—Ifosfamide—testicular cancer	0.00046	0.00159	CcSEcCtD
Ranitidine—Cardiac arrest—Doxorubicin—testicular cancer	0.000459	0.00159	CcSEcCtD
Ranitidine—Body temperature increased—Ifosfamide—testicular cancer	0.000458	0.00158	CcSEcCtD
Ranitidine—Abdominal pain—Ifosfamide—testicular cancer	0.000458	0.00158	CcSEcCtD
Ranitidine—Pancytopenia—Methotrexate—testicular cancer	0.000458	0.00158	CcSEcCtD
Ranitidine—Anaphylactic shock—Etoposide—testicular cancer	0.000458	0.00158	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000455	0.00157	CcSEcCtD
Ranitidine—Blood creatinine increased—Doxorubicin—testicular cancer	0.000452	0.00156	CcSEcCtD
Ranitidine—Dysphagia—Epirubicin—testicular cancer	0.000451	0.00156	CcSEcCtD
Ranitidine—Neutropenia—Methotrexate—testicular cancer	0.000451	0.00156	CcSEcCtD
Ranitidine—Thrombocytopenia—Etoposide—testicular cancer	0.000448	0.00155	CcSEcCtD
Ranitidine—Tachycardia—Etoposide—testicular cancer	0.000447	0.00154	CcSEcCtD
Ranitidine—Eosinophilia—Epirubicin—testicular cancer	0.000447	0.00154	CcSEcCtD
Ranitidine—Dyspnoea—Cisplatin—testicular cancer	0.000445	0.00154	CcSEcCtD
Ranitidine—Erectile dysfunction—Methotrexate—testicular cancer	0.000444	0.00153	CcSEcCtD
Ranitidine—Hyperhidrosis—Etoposide—testicular cancer	0.000442	0.00153	CcSEcCtD
Ranitidine—Pancreatitis—Epirubicin—testicular cancer	0.000442	0.00153	CcSEcCtD
Ranitidine—Abdominal pain upper—Doxorubicin—testicular cancer	0.000441	0.00152	CcSEcCtD
Ranitidine—Photosensitivity reaction—Methotrexate—testicular cancer	0.00044	0.00152	CcSEcCtD
Ranitidine—Angina pectoris—Epirubicin—testicular cancer	0.000439	0.00152	CcSEcCtD
Ranitidine—Breast disorder—Doxorubicin—testicular cancer	0.000436	0.00151	CcSEcCtD
Ranitidine—Diarrhoea—Dactinomycin—testicular cancer	0.000433	0.0015	CcSEcCtD
Ranitidine—Pneumonia—Methotrexate—testicular cancer	0.000432	0.00149	CcSEcCtD
Ranitidine—Vomiting—Bleomycin—testicular cancer	0.000431	0.00149	CcSEcCtD
Ranitidine—Pancytopenia—Epirubicin—testicular cancer	0.000428	0.00148	CcSEcCtD
Ranitidine—Hypotension—Etoposide—testicular cancer	0.000428	0.00148	CcSEcCtD
Ranitidine—Rash—Bleomycin—testicular cancer	0.000427	0.00148	CcSEcCtD
Ranitidine—Pain—Cisplatin—testicular cancer	0.000427	0.00148	CcSEcCtD
Ranitidine—Dermatitis—Bleomycin—testicular cancer	0.000427	0.00148	CcSEcCtD
Ranitidine—Hypersensitivity—Ifosfamide—testicular cancer	0.000427	0.00148	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000426	0.00147	CcSEcCtD
Ranitidine—Neutropenia—Epirubicin—testicular cancer	0.000422	0.00146	CcSEcCtD
Ranitidine—Dysphagia—Doxorubicin—testicular cancer	0.000417	0.00144	CcSEcCtD
Ranitidine—Eosinophilia—Doxorubicin—testicular cancer	0.000413	0.00143	CcSEcCtD
Ranitidine—Sweating—Methotrexate—testicular cancer	0.000412	0.00142	CcSEcCtD
Ranitidine—Photosensitivity reaction—Epirubicin—testicular cancer	0.000412	0.00142	CcSEcCtD
Ranitidine—Feeling abnormal—Cisplatin—testicular cancer	0.000412	0.00142	CcSEcCtD
Ranitidine—Pruritus—Ifosfamide—testicular cancer	0.00041	0.00142	CcSEcCtD
Ranitidine—Pancreatitis—Doxorubicin—testicular cancer	0.000409	0.00141	CcSEcCtD
Ranitidine—Weight decreased—Epirubicin—testicular cancer	0.000408	0.00141	CcSEcCtD
Ranitidine—Dyspnoea—Etoposide—testicular cancer	0.000408	0.00141	CcSEcCtD
Ranitidine—Somnolence—Etoposide—testicular cancer	0.000407	0.00141	CcSEcCtD
Ranitidine—Angina pectoris—Doxorubicin—testicular cancer	0.000407	0.00141	CcSEcCtD
Ranitidine—Pneumonia—Epirubicin—testicular cancer	0.000404	0.0014	CcSEcCtD
Ranitidine—Nausea—Bleomycin—testicular cancer	0.000403	0.00139	CcSEcCtD
Ranitidine—Vomiting—Dactinomycin—testicular cancer	0.000402	0.00139	CcSEcCtD
Ranitidine—Agranulocytosis—Methotrexate—testicular cancer	0.000401	0.00139	CcSEcCtD
Ranitidine—Rash—Dactinomycin—testicular cancer	0.000399	0.00138	CcSEcCtD
Ranitidine—Diarrhoea—Ifosfamide—testicular cancer	0.000396	0.00137	CcSEcCtD
Ranitidine—Pancytopenia—Doxorubicin—testicular cancer	0.000396	0.00137	CcSEcCtD
Ranitidine—Body temperature increased—Cisplatin—testicular cancer	0.000395	0.00136	CcSEcCtD
Ranitidine—Jaundice—Epirubicin—testicular cancer	0.000392	0.00136	CcSEcCtD
Ranitidine—Pain—Etoposide—testicular cancer	0.000391	0.00135	CcSEcCtD
Ranitidine—Constipation—Etoposide—testicular cancer	0.000391	0.00135	CcSEcCtD
Ranitidine—Neutropenia—Doxorubicin—testicular cancer	0.00039	0.00135	CcSEcCtD
Ranitidine—Hepatitis—Methotrexate—testicular cancer	0.000386	0.00133	CcSEcCtD
Ranitidine—Sweating—Epirubicin—testicular cancer	0.000386	0.00133	CcSEcCtD
Ranitidine—Dizziness—Ifosfamide—testicular cancer	0.000383	0.00132	CcSEcCtD
Ranitidine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000381	0.00132	CcSEcCtD
Ranitidine—Weight decreased—Doxorubicin—testicular cancer	0.000378	0.00131	CcSEcCtD
Ranitidine—Feeling abnormal—Etoposide—testicular cancer	0.000377	0.0013	CcSEcCtD
Ranitidine—Nausea—Dactinomycin—testicular cancer	0.000376	0.0013	CcSEcCtD
Ranitidine—Agranulocytosis—Epirubicin—testicular cancer	0.000375	0.0013	CcSEcCtD
Ranitidine—Pneumonia—Doxorubicin—testicular cancer	0.000374	0.00129	CcSEcCtD
Ranitidine—Vomiting—Ifosfamide—testicular cancer	0.000368	0.00127	CcSEcCtD
Ranitidine—Hypersensitivity—Cisplatin—testicular cancer	0.000368	0.00127	CcSEcCtD
Ranitidine—Bradycardia—Epirubicin—testicular cancer	0.000368	0.00127	CcSEcCtD
Ranitidine—Rash—Ifosfamide—testicular cancer	0.000365	0.00126	CcSEcCtD
Ranitidine—Dermatitis—Ifosfamide—testicular cancer	0.000365	0.00126	CcSEcCtD
Ranitidine—Erythema multiforme—Methotrexate—testicular cancer	0.000365	0.00126	CcSEcCtD
Ranitidine—Urticaria—Etoposide—testicular cancer	0.000364	0.00126	CcSEcCtD
Ranitidine—Jaundice—Doxorubicin—testicular cancer	0.000363	0.00125	CcSEcCtD
Ranitidine—Body temperature increased—Etoposide—testicular cancer	0.000362	0.00125	CcSEcCtD
Ranitidine—Abdominal pain—Etoposide—testicular cancer	0.000362	0.00125	CcSEcCtD
Ranitidine—Hepatitis—Epirubicin—testicular cancer	0.000361	0.00125	CcSEcCtD
Ranitidine—Sweating—Doxorubicin—testicular cancer	0.000357	0.00123	CcSEcCtD
Ranitidine—Agranulocytosis—Doxorubicin—testicular cancer	0.000347	0.0012	CcSEcCtD
Ranitidine—Nausea—Ifosfamide—testicular cancer	0.000344	0.00119	CcSEcCtD
Ranitidine—Diarrhoea—Cisplatin—testicular cancer	0.000342	0.00118	CcSEcCtD
Ranitidine—Erythema multiforme—Epirubicin—testicular cancer	0.000341	0.00118	CcSEcCtD
Ranitidine—Alopecia—Methotrexate—testicular cancer	0.000341	0.00118	CcSEcCtD
Ranitidine—Bradycardia—Doxorubicin—testicular cancer	0.00034	0.00118	CcSEcCtD
Ranitidine—Hypersensitivity—Etoposide—testicular cancer	0.000337	0.00117	CcSEcCtD
Ranitidine—Erythema—Methotrexate—testicular cancer	0.000336	0.00116	CcSEcCtD
Ranitidine—Hepatitis—Doxorubicin—testicular cancer	0.000334	0.00115	CcSEcCtD
Ranitidine—Pruritus—Etoposide—testicular cancer	0.000324	0.00112	CcSEcCtD
Ranitidine—Arrhythmia—Epirubicin—testicular cancer	0.000323	0.00111	CcSEcCtD
Ranitidine—Alopecia—Epirubicin—testicular cancer	0.000319	0.0011	CcSEcCtD
Ranitidine—Vomiting—Cisplatin—testicular cancer	0.000318	0.0011	CcSEcCtD
Ranitidine—Vision blurred—Methotrexate—testicular cancer	0.000316	0.00109	CcSEcCtD
Ranitidine—Erythema multiforme—Doxorubicin—testicular cancer	0.000316	0.00109	CcSEcCtD
Ranitidine—Rash—Cisplatin—testicular cancer	0.000315	0.00109	CcSEcCtD
Ranitidine—Dermatitis—Cisplatin—testicular cancer	0.000315	0.00109	CcSEcCtD
Ranitidine—Erythema—Epirubicin—testicular cancer	0.000314	0.00109	CcSEcCtD
Ranitidine—Diarrhoea—Etoposide—testicular cancer	0.000313	0.00108	CcSEcCtD
Ranitidine—Ill-defined disorder—Methotrexate—testicular cancer	0.000312	0.00108	CcSEcCtD
Ranitidine—Anaemia—Methotrexate—testicular cancer	0.00031	0.00107	CcSEcCtD
Ranitidine—Malaise—Methotrexate—testicular cancer	0.000303	0.00105	CcSEcCtD
Ranitidine—Dizziness—Etoposide—testicular cancer	0.000303	0.00105	CcSEcCtD
Ranitidine—Vertigo—Methotrexate—testicular cancer	0.000302	0.00104	CcSEcCtD
Ranitidine—Leukopenia—Methotrexate—testicular cancer	0.000301	0.00104	CcSEcCtD
Ranitidine—Arrhythmia—Doxorubicin—testicular cancer	0.000298	0.00103	CcSEcCtD
Ranitidine—Nausea—Cisplatin—testicular cancer	0.000297	0.00103	CcSEcCtD
Ranitidine—Vision blurred—Epirubicin—testicular cancer	0.000296	0.00102	CcSEcCtD
Ranitidine—Alopecia—Doxorubicin—testicular cancer	0.000295	0.00102	CcSEcCtD
Ranitidine—Ill-defined disorder—Epirubicin—testicular cancer	0.000292	0.00101	CcSEcCtD
Ranitidine—Vomiting—Etoposide—testicular cancer	0.000291	0.00101	CcSEcCtD
Ranitidine—Erythema—Doxorubicin—testicular cancer	0.000291	0.00101	CcSEcCtD
Ranitidine—Anaemia—Epirubicin—testicular cancer	0.00029	0.001	CcSEcCtD
Ranitidine—Agitation—Epirubicin—testicular cancer	0.000289	0.000998	CcSEcCtD
Ranitidine—Rash—Etoposide—testicular cancer	0.000289	0.000997	CcSEcCtD
Ranitidine—Dermatitis—Etoposide—testicular cancer	0.000288	0.000996	CcSEcCtD
Ranitidine—Headache—Etoposide—testicular cancer	0.000287	0.000991	CcSEcCtD
Ranitidine—Arthralgia—Methotrexate—testicular cancer	0.000286	0.000988	CcSEcCtD
Ranitidine—Chest pain—Methotrexate—testicular cancer	0.000286	0.000988	CcSEcCtD
Ranitidine—Myalgia—Methotrexate—testicular cancer	0.000286	0.000988	CcSEcCtD
Ranitidine—Malaise—Epirubicin—testicular cancer	0.000283	0.00098	CcSEcCtD
Ranitidine—Discomfort—Methotrexate—testicular cancer	0.000282	0.000976	CcSEcCtD
Ranitidine—Vertigo—Epirubicin—testicular cancer	0.000282	0.000976	CcSEcCtD
Ranitidine—Leukopenia—Epirubicin—testicular cancer	0.000281	0.000972	CcSEcCtD
Ranitidine—Confusional state—Methotrexate—testicular cancer	0.000276	0.000955	CcSEcCtD
Ranitidine—Anaphylactic shock—Methotrexate—testicular cancer	0.000274	0.000947	CcSEcCtD
Ranitidine—Vision blurred—Doxorubicin—testicular cancer	0.000274	0.000947	CcSEcCtD
Ranitidine—Nausea—Etoposide—testicular cancer	0.000272	0.00094	CcSEcCtD
Ranitidine—Ill-defined disorder—Doxorubicin—testicular cancer	0.00027	0.000933	CcSEcCtD
Ranitidine—Anaemia—Doxorubicin—testicular cancer	0.000269	0.000929	CcSEcCtD
Ranitidine—Thrombocytopenia—Methotrexate—testicular cancer	0.000268	0.000928	CcSEcCtD
Ranitidine—Chest pain—Epirubicin—testicular cancer	0.000268	0.000925	CcSEcCtD
Ranitidine—Arthralgia—Epirubicin—testicular cancer	0.000268	0.000925	CcSEcCtD
Ranitidine—Myalgia—Epirubicin—testicular cancer	0.000268	0.000925	CcSEcCtD
Ranitidine—Agitation—Doxorubicin—testicular cancer	0.000267	0.000924	CcSEcCtD
Ranitidine—Hyperhidrosis—Methotrexate—testicular cancer	0.000265	0.000916	CcSEcCtD
Ranitidine—Discomfort—Epirubicin—testicular cancer	0.000264	0.000914	CcSEcCtD
Ranitidine—Malaise—Doxorubicin—testicular cancer	0.000262	0.000906	CcSEcCtD
Ranitidine—Vertigo—Doxorubicin—testicular cancer	0.000261	0.000903	CcSEcCtD
Ranitidine—Leukopenia—Doxorubicin—testicular cancer	0.00026	0.0009	CcSEcCtD
Ranitidine—Confusional state—Epirubicin—testicular cancer	0.000259	0.000894	CcSEcCtD
Ranitidine—Anaphylactic shock—Epirubicin—testicular cancer	0.000256	0.000887	CcSEcCtD
Ranitidine—Hypotension—Methotrexate—testicular cancer	0.000256	0.000885	CcSEcCtD
Ranitidine—Thrombocytopenia—Epirubicin—testicular cancer	0.000251	0.000868	CcSEcCtD
Ranitidine—Tachycardia—Epirubicin—testicular cancer	0.00025	0.000865	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00025	0.000863	CcSEcCtD
Ranitidine—Hyperhidrosis—Epirubicin—testicular cancer	0.000248	0.000857	CcSEcCtD
Ranitidine—Insomnia—Methotrexate—testicular cancer	0.000248	0.000857	CcSEcCtD
Ranitidine—Arthralgia—Doxorubicin—testicular cancer	0.000248	0.000856	CcSEcCtD
Ranitidine—Chest pain—Doxorubicin—testicular cancer	0.000248	0.000856	CcSEcCtD
Ranitidine—Myalgia—Doxorubicin—testicular cancer	0.000248	0.000856	CcSEcCtD
Ranitidine—Discomfort—Doxorubicin—testicular cancer	0.000245	0.000846	CcSEcCtD
Ranitidine—Dyspnoea—Methotrexate—testicular cancer	0.000244	0.000845	CcSEcCtD
Ranitidine—Somnolence—Methotrexate—testicular cancer	0.000244	0.000842	CcSEcCtD
Ranitidine—Hypotension—Epirubicin—testicular cancer	0.00024	0.000829	CcSEcCtD
Ranitidine—Confusional state—Doxorubicin—testicular cancer	0.000239	0.000827	CcSEcCtD
Ranitidine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000237	0.00082	CcSEcCtD
Ranitidine—Pain—Methotrexate—testicular cancer	0.000234	0.00081	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000234	0.000808	CcSEcCtD
Ranitidine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000232	0.000803	CcSEcCtD
Ranitidine—Insomnia—Epirubicin—testicular cancer	0.000232	0.000802	CcSEcCtD
Ranitidine—Tachycardia—Doxorubicin—testicular cancer	0.000232	0.000801	CcSEcCtD
Ranitidine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000229	0.000793	CcSEcCtD
Ranitidine—Dyspnoea—Epirubicin—testicular cancer	0.000229	0.00079	CcSEcCtD
Ranitidine—Somnolence—Epirubicin—testicular cancer	0.000228	0.000788	CcSEcCtD
Ranitidine—Feeling abnormal—Methotrexate—testicular cancer	0.000226	0.000781	CcSEcCtD
Ranitidine—Hypotension—Doxorubicin—testicular cancer	0.000222	0.000767	CcSEcCtD
Ranitidine—Pain—Epirubicin—testicular cancer	0.000219	0.000758	CcSEcCtD
Ranitidine—Constipation—Epirubicin—testicular cancer	0.000219	0.000758	CcSEcCtD
Ranitidine—Urticaria—Methotrexate—testicular cancer	0.000218	0.000753	CcSEcCtD
Ranitidine—Body temperature increased—Methotrexate—testicular cancer	0.000217	0.000749	CcSEcCtD
Ranitidine—Abdominal pain—Methotrexate—testicular cancer	0.000217	0.000749	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000216	0.000747	CcSEcCtD
Ranitidine—Insomnia—Doxorubicin—testicular cancer	0.000215	0.000742	CcSEcCtD
Ranitidine—Dyspnoea—Doxorubicin—testicular cancer	0.000212	0.000731	CcSEcCtD
Ranitidine—Feeling abnormal—Epirubicin—testicular cancer	0.000211	0.000731	CcSEcCtD
Ranitidine—Somnolence—Doxorubicin—testicular cancer	0.000211	0.000729	CcSEcCtD
Ranitidine—Urticaria—Epirubicin—testicular cancer	0.000204	0.000704	CcSEcCtD
Ranitidine—Pain—Doxorubicin—testicular cancer	0.000203	0.000702	CcSEcCtD
Ranitidine—Constipation—Doxorubicin—testicular cancer	0.000203	0.000702	CcSEcCtD
Ranitidine—Body temperature increased—Epirubicin—testicular cancer	0.000203	0.000701	CcSEcCtD
Ranitidine—Abdominal pain—Epirubicin—testicular cancer	0.000203	0.000701	CcSEcCtD
Ranitidine—Hypersensitivity—Methotrexate—testicular cancer	0.000202	0.000698	CcSEcCtD
Ranitidine—Feeling abnormal—Doxorubicin—testicular cancer	0.000196	0.000676	CcSEcCtD
Ranitidine—Pruritus—Methotrexate—testicular cancer	0.000194	0.00067	CcSEcCtD
Ranitidine—Hypersensitivity—Epirubicin—testicular cancer	0.000189	0.000653	CcSEcCtD
Ranitidine—Urticaria—Doxorubicin—testicular cancer	0.000189	0.000652	CcSEcCtD
Ranitidine—Body temperature increased—Doxorubicin—testicular cancer	0.000188	0.000649	CcSEcCtD
Ranitidine—Abdominal pain—Doxorubicin—testicular cancer	0.000188	0.000649	CcSEcCtD
Ranitidine—Diarrhoea—Methotrexate—testicular cancer	0.000188	0.000648	CcSEcCtD
Ranitidine—Pruritus—Epirubicin—testicular cancer	0.000181	0.000627	CcSEcCtD
Ranitidine—Dizziness—Methotrexate—testicular cancer	0.000181	0.000627	CcSEcCtD
Ranitidine—Diarrhoea—Epirubicin—testicular cancer	0.000175	0.000607	CcSEcCtD
Ranitidine—Hypersensitivity—Doxorubicin—testicular cancer	0.000175	0.000604	CcSEcCtD
Ranitidine—Vomiting—Methotrexate—testicular cancer	0.000174	0.000602	CcSEcCtD
Ranitidine—Rash—Methotrexate—testicular cancer	0.000173	0.000597	CcSEcCtD
Ranitidine—Dermatitis—Methotrexate—testicular cancer	0.000173	0.000597	CcSEcCtD
Ranitidine—Headache—Methotrexate—testicular cancer	0.000172	0.000594	CcSEcCtD
Ranitidine—Dizziness—Epirubicin—testicular cancer	0.00017	0.000586	CcSEcCtD
Ranitidine—Pruritus—Doxorubicin—testicular cancer	0.000168	0.00058	CcSEcCtD
Ranitidine—Vomiting—Epirubicin—testicular cancer	0.000163	0.000564	CcSEcCtD
Ranitidine—Nausea—Methotrexate—testicular cancer	0.000163	0.000563	CcSEcCtD
Ranitidine—Diarrhoea—Doxorubicin—testicular cancer	0.000162	0.000561	CcSEcCtD
Ranitidine—Rash—Epirubicin—testicular cancer	0.000162	0.000559	CcSEcCtD
Ranitidine—Dermatitis—Epirubicin—testicular cancer	0.000162	0.000559	CcSEcCtD
Ranitidine—Headache—Epirubicin—testicular cancer	0.000161	0.000555	CcSEcCtD
Ranitidine—Dizziness—Doxorubicin—testicular cancer	0.000157	0.000543	CcSEcCtD
Ranitidine—Nausea—Epirubicin—testicular cancer	0.000152	0.000527	CcSEcCtD
Ranitidine—Vomiting—Doxorubicin—testicular cancer	0.000151	0.000522	CcSEcCtD
Ranitidine—Rash—Doxorubicin—testicular cancer	0.00015	0.000517	CcSEcCtD
Ranitidine—Dermatitis—Doxorubicin—testicular cancer	0.000149	0.000517	CcSEcCtD
Ranitidine—Headache—Doxorubicin—testicular cancer	0.000149	0.000514	CcSEcCtD
Ranitidine—Nausea—Doxorubicin—testicular cancer	0.000141	0.000487	CcSEcCtD
